Appili Therapeutics Inc (PK) (APLIF)
USOTC
Year End March 30 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Return on Assets (%) | -126.701 | -60.151 | -97.152 | -188.864 | -161.959 | -163.609 |
Return on Equity (%) | -195.928 | -81.658 | -132.651 | -529.804 | 173.285 | 41.273 |
Return on Invested Capital (%) | -159.38 | -70.733 | -122.344 | -308.196 | -884.166 | 45.16 |
Operating Margin (%) | N/A | -2715.578 | N/A | -1691.229 | -2428.443 | -251.511 |
Net Profit Margin (%) | N/A | -2721.608 | N/A | -1805.751 | -2767.365 | -457.195 |
Book Value Per Share | 0.564 | 0.191 | 0.203 | -0.046 | -0.061 | -0.09 |
Earnings Per Share | -0.552 | -0.117 | -0.228 | -0.352 | -0.076 | -0.031 |
Cash Per Share | 0.691 | 0.227 | 0.176 | 0.094 | 0.02 | 0.001 |
Working Capital Per Share | 0.689 | 0.21 | 0.217 | 0.022 | 0.001 | -0.083 |
Operating Profit Per Share | 0.277 | 0.019 | 0.021 | 0.034 | 0.004 | 0.055 |
EBIT Per Share | -0.552 | -0.117 | -0.228 | -0.352 | -0.076 | -0.031 |
EBITDA Per Share | -0.552 | -0.117 | -0.228 | -0.352 | -0.076 | -0.031 |
Free Cash Flow Per Share | -0.553 | -0.117 | -0.228 | -0.353 | -0.076 | -0.031 |
Year End March 30 2024 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Current Ratio | 5.004 | 8.062 | 3.956 | 1.235 | 1.047 | 0.127 |
Quick Ratio | 4.039 | 7.649 | 3.493 | 0.999 | 0.828 | 0.108 |
Inventory Turnover (Days) | N/A | 71.533 | N/A | N/A | N/A | N/A |
Shares Outstanding | 7.84M | 46.4M | 62.78M | 71.27M | 121.27M | 121.27M |
Market Cap | 2.84M |
Price to Earnings Ratio | -0.96 |
Price to Sales Ratio | 0.54 |
Price to Cash Ratio | 37.5 |
Price to Book Ratio | -0.33 |
Dividend Yield | - |
Shares Outstanding | 121.27M |
Average Volume (1 week) | 367.02k |
Average Volume (1 Month) | 100.04k |
52 Week Change | -44.30% |
52 Week High | 0.069 |
52 Week Low | 0.0162 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.